- Ozempic Could Be Lifesaving for Thousands of Americans a Year, Study Finds Gizmodo
- New value nonaccomplishment drugs rise questions of access, costs The Boston Globe
- Expanding entree to GLP-1 weight-loss drugs could prevention thousands of lives News-Medical.Net
- Healthy Returns: Covering value nonaccomplishment drugs could outgo Medicare $35 cardinal done 2034 CNBC
- Key Lessons for Ethical and Affordable Access to GLP-1 Drugs Like Ozempic and Wegovy Leonard Davis Institute